علاج متلازمة كوغان بالعلاج البيولوجي المضاد لـ TNF

References

DOI: 10.1016/j.revmed.2024.09.007

• More recently, anti-TNFα agents, particularly infliximab, have been offered in addition to steroid therapy, either alone or in combination with disease-modifying antirheumatic drugs (DMARDs).
• Data on other biologic therapies is even more limited; five isolated cases report the efficacy of tocilizumab, and two cases of rituximab.
• Combination with anti-TNF therapy should be promptly discussed.